Zynext Ventures invests in Illexcor Therapeutics to advance novel oral therapy for sickle cell disease ...Middle East

News by : (PR Newswire) -

PENNINGTON, N.J., March 12, 2025 /PRNewswire/ -- Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its investment in Illexcor Therapeutics (Illexcor), a pioneering biopharmaceutical company developing next-generation oral...

Read More Details
Finally We wish PressBee provided you with enough information of ( Zynext Ventures invests in Illexcor Therapeutics to advance novel oral therapy for sickle cell disease )

Also on site :

Most Viewed News
جديد الاخبار